Learn about clinical breakthroughs and advances in patient care during the educational symposia at the Society of Critical Care Medicine’s (SCCM) 46th Critical Care Congress. Each stimulating session is presented by leading experts in critical care and offers a thorough analysis of the developments and issues affecting most intensive care unit (ICU) environments. These sessions are complimentary for all Congress registrants, and no additional registration is needed to attend.
Evidence-Based Management of Hepatorenal Syndrome Type 1 in Critical Care: Preserving Renal Function in Patients with Portal Hypertension
Supported by an educational grant from Mallinckrodt Pharmaceuticals
This session will review the current knowledge on pathology and definitions for hepatorenal syndrome (HRS) as well as assessment and differential diagnosis of HRS in cirrhotic patients. Critical care team decision-making regarding plasma revolumization and timing of pharmacologic options will also be discussed.
The Modern Approach to the Diagnosis and Treatment of Shock
Supported by an educational grant from La Jolla Pharmaceutical Company
This symposium will explore emerging therapeutic strategies, preserving end-organ perfusion and volumetric assessment in shock.
Anticoagulant Therapy: Where We Are and Where We Are Heading
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
This session will discuss non-vitamin K antagonist oral anticoagulants, new antiplatelet agents (thienopyridines), and emergent management of bleeding and reversal of anticoagulant and antiplatelet agents.
These symposia will be held Sunday, January 22, 2017, at the Hilton Hawaiian Village in the Tapa Tower Ballrooms. Seating is on a first-come, first-served basis. Light refreshments and beverages will be available before each symposium, beginning at 3:00 p.m. The sessions will start promptly at 3:30 p.m. More information is available at www.sccm.org/AfternoonSymposia.